{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T17:37:40Z","timestamp":1788716260226,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.biopha.2022.112694","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T21:35:57Z","timestamp":1644010557000},"page":"112694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Sesquiterpene lactones as potential therapeutic agents against Naegleria fowleri"],"prefix":"10.1016","volume":"147","author":[{"given":"I\u00f1igo","family":"Arberas-Jim\u00e9nez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitor","family":"Rizo-Liendo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nath\u00e1lia","family":"Nocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Sifaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Chao-Pellicer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda L.","family":"Souto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Su\u00e1rez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana R.","family":"D\u00edaz-Marrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 J.","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 E.","family":"Pi\u00f1ero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Lorenzo-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.112694_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/genes10080618","article-title":"Host invasion by pathogenic amoebae: epithelial disruption by parasite proteins","volume":"10","author":"Betanzos","year":"2019","journal-title":"Genes"},{"key":"10.1016\/j.biopha.2022.112694_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104784","article-title":"The type 2 statins, cerivastatin, rosuvastatin and pitavastatin eliminate Naegleria fowleri at low concentrations and by induction of programmed cell death (PCD)","volume":"110","author":"Rizo-Liendo","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2022.112694_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-74729-y","article-title":"Laurinterol from Laurencia johnstonii eliminates Naegleria fowleri triggering PCD by inhibition of ATPases","volume":"10","author":"Arberas-Jim\u00e9nez","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.112694_bib4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.actatropica.2016.09.009","article-title":"Biology and pathogenesis of Naegleria fowleri","volume":"164","author":"Siddiqui","year":"2016","journal-title":"Acta Trop."},{"key":"10.1016\/j.biopha.2022.112694_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pt.2019.10.008","article-title":"Is naegleria fowleri an emerging parasite?","volume":"36","author":"Maciver","year":"2020","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.biopha.2022.112694_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8050789","article-title":"Evaluation of indolocarbazoles from streptomyces sanyensis as a novel source of therapeutic agents against the brain-eating amoeba naegleria fowleri","volume":"8","author":"Rizo-Liendo","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.biopha.2022.112694_bib7","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/bmj.2.5464.734-a","article-title":"Acute pyogenic meningitis probably due to Acanthamoeba sp.: a preliminary report.","volume":"2","author":"Fowler","year":"1965","journal-title":"Br. Med. J."},{"key":"10.1016\/j.biopha.2022.112694_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exppara.2018.02.010","article-title":"The therapeutic strategies against Naegleria fowleri","volume":"187","author":"Bellini","year":"2018","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.biopha.2022.112694_bib9","unstructured":"Centers for Disease Control and Prevention (CDC), Case Report Data & Graphs, (2020). https:\/\/www.cdc.gov\/parasites\/naegleria\/graphs.html."},{"key":"10.1016\/j.biopha.2022.112694_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1473-3099(19)30675-9","article-title":"Naegleria fowleri in Pakistan","volume":"20","author":"Ali","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.biopha.2022.112694_bib11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijid.2018.05.001","article-title":"Identification and molecular typing of Naegleria fowleri from a patient with primary amebic meningoencephalitis in China","volume":"72","author":"Zhang","year":"2018","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.biopha.2022.112694_bib12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3201\/eid2401.170545","article-title":"Estimation of undiagnosed <em>Naegleria fowleri<\/em> primary amebic meningoencephalitis, United States","volume":"24","author":"Matanock","year":"2018","journal-title":"Emerg. Infect. Dis. J."},{"key":"10.1016\/j.biopha.2022.112694_bib13","doi-asserted-by":"crossref","first-page":"6677","DOI":"10.1128\/AAC.01293-15","article-title":"Naegleria fowleri: pathogenesis, diagnosis, and treatment options","volume":"59","author":"Grace","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2022.112694_bib14","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1021\/acschemneuro.6b00232","article-title":"Naegleria fowleri: diagnosis, pathophysiology of brain inflammation, and antimicrobial treatments","volume":"7","author":"Pugh","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biopha.2022.112694_bib15","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1542\/peds.2014-2292","article-title":"Successful treatment of an adolescent with Naegleria fowleri primary amebic meningoencephalitis","volume":"135","author":"Linam","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.biopha.2022.112694_bib16","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.4269\/ajtmh.17-0110","article-title":"Case series of naegleria fowleri primary ameobic meningoencephalitis from Karachi, Pakistan","volume":"97","author":"Ghanchi","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.biopha.2022.112694_bib17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/tp.TP_34_19","article-title":"Survival of primary amebic meningoencephalitis by Naegleria fowleri: first reported case from Tamil Nadu, South India","volume":"10","author":"Perumalsamy","year":"2020","journal-title":"Trop. Parasitol."},{"key":"10.1016\/j.biopha.2022.112694_bib18","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/cid\/civ1021","article-title":"Use of the novel therapeutic agent miltefosine for the treatment of primary amebic meningoencephalitis: report of 1 fatal and 1 surviving case","volume":"62","author":"Cope","year":"2016","journal-title":"Clin. Infect. Dis. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.biopha.2022.112694_bib19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.riam.2009.06.003","article-title":"Amphotericin B: side effects and toxicity","volume":"26","author":"Laniado-Labor\u00edn","year":"2009","journal-title":"Rev. Iberoam. Micol."},{"key":"10.1016\/j.biopha.2022.112694_bib20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1021\/acschemneuro.0c00685","article-title":"Exploring the anti-infective value of inuloxin a isolated from inula viscosa against the brain-eating amoeba (naegleria fowleri) by activation of programmed cell death","volume":"12","author":"Zeouk","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biopha.2022.112694_bib21","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4062\/biomolther.2016.181","article-title":"Marine-derived pharmaceuticals - challenges and opportunities","volume":"24","author":"Lindequist","year":"2016","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.biopha.2022.112694_bib22","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.3390\/app10093001","article-title":"Applications of sesquiterpene lactones: a review of some potential success cases","volume":"10","author":"Moujir","year":"2020","journal-title":"Appl. Sci."},{"key":"10.1016\/j.biopha.2022.112694_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.fitote.2017.05.017","article-title":"Sesquiterpene lactones with unusual structure. Their biogenesis and biological activity","volume":"121","author":"Adekenov","year":"2017","journal-title":"Fitoterapia"},{"key":"10.1016\/j.biopha.2022.112694_bib24","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1080\/14786419.2019.1679132","article-title":"Cytotoxic sesquiterpenoid quinones from South China Sea sponge Dysidea sp","volume":"35","author":"Luo","year":"2021","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.biopha.2022.112694_bib25","first-page":"1341","article-title":"P. Van Kiema, Sesquiterpenes from the Vietnamese Marine Sponge Dysidea fragilis","volume":"10","author":"Cue","year":"2015","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.biopha.2022.112694_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bse.2011.10.012","article-title":"Seco-germacrane anhydride: occurrence of a sesquiterpene lactone in the gorgonian coral Menella sp. (Plexauridae)","volume":"40","author":"Sung","year":"2012","journal-title":"Biochem. Syst. Ecol."},{"key":"10.1016\/j.biopha.2022.112694_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104682","article-title":"Antiamoebic effects of sesquiterpene lactones isolated from the zoanthid Palythoa aff. clavata","volume":"108","author":"Rodr\u00edguez-Exp\u00f3sito","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2022.112694_bib28","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0040-4020(01)81958-X","article-title":"New germacrane derivatives from gorgonian octocorals of the genus Pseudopterogorgia","volume":"46","author":"Chan","year":"1990","journal-title":"Tetrahedron"},{"key":"10.1016\/j.biopha.2022.112694_bib29","first-page":"913","article-title":"C. Van Minh, Guaiane Sesquiterpenoids from the Gorgonian Menella woodin","volume":"11","author":"Lyakhova","year":"2016","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.biopha.2022.112694_bib30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/13102818.2010.10817819","article-title":"Pharmacological activity of sesquiterpene lactones","volume":"24","author":"Mateji\u0107","year":"2010","journal-title":"Biotechnol. Biotechnol. Equip."},{"key":"10.1016\/j.biopha.2022.112694_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13070991","article-title":"Sesquiterpene lactones: promising natural compounds to fight inflammation","volume":"13","author":"Matos","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2022.112694_bib32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/1568011053765976","article-title":"Anti-cancer potential of sesquiterpene lactones: bioactivity and molecular mechanisms","volume":"5","author":"Zhang","year":"2005","journal-title":"Curr. Med. Chem. Anticancer. Agents"},{"key":"10.1016\/j.biopha.2022.112694_bib33","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.2174\/0929867323666160510123255","article-title":"Development of anticancer agents from plant-derived sesquiterpene lactones","volume":"23","author":"Ren","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112694_bib34","doi-asserted-by":"crossref","first-page":"15410","DOI":"10.1021\/acs.jmedchem.0c01449","article-title":"Development of potential antitumor agents from the scaffolds of plant-derived terpenoid lactones","volume":"63","author":"Ren","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112694_bib35","first-page":"1095","article-title":"Antikinetoplastid activity of sesquiterpenes isolated from the zoanthid palythoa aff. clavata","volume":"14","author":"Bethencourt-Estrella","year":"2021","journal-title":"Pharm. (Basel, Switz.)"},{"key":"10.1016\/j.biopha.2022.112694_bib36","first-page":"122","article-title":"In vitro activity of statins against naegleria fowleri","volume":"8","author":"Rizo-Liendo","year":"2019","journal-title":"Pathog. (Basel, Switz.)"},{"key":"10.1016\/j.biopha.2022.112694_bib37","first-page":"1190","article-title":"Selective activity of oleanolic and maslinic acids on the amastigote form of leishmania Spp., Iran","volume":"16","author":"Sifaoui","year":"2017","journal-title":"J. Pharm. Res. Ijpr."},{"key":"10.1016\/j.biopha.2022.112694_bib38","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1038\/s41598-018-26914-3","article-title":"Toxic effects of selected proprietary dry eye drops on Acanthamoeba","volume":"8","author":"Sifaoui","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.112694_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005929","article-title":"Assessment of sesquiterpene lactones isolated from Mikania plants species for their potential efficacy against Trypanosoma cruzi and Leishmania sp","volume":"11","author":"Laurella","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.biopha.2022.112694_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24203737","article-title":"Natural sesquiterpene lactones of the 4,15-iso-atriplicolide type are inhibitors of trypanothione reductase","volume":"24","author":"Lenz","year":"2019","journal-title":"Mol"},{"key":"10.1016\/j.biopha.2022.112694_bib41","article-title":"In vitro antiplasmodial activity of sesquiterpene lactones from ambrosia tenuifolia, evidence-based complement","volume":"2011","author":"S\u00fclsen","year":"2011","journal-title":"Altern. Med."},{"key":"10.1016\/j.biopha.2022.112694_bib42","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1099\/mic.0.000500","article-title":"Amphotericin B induces apoptosis-like programmed cell death in Naegleria fowleri and Naegleria gruberi","volume":"163","author":"C\u00e1rdenas-Z\u00fa\u00f1iga","year":"2017","journal-title":"Microbiology"},{"key":"10.1016\/j.biopha.2022.112694_bib43","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ceb.2004.09.011","article-title":"Death by design: apoptosis, necrosis and autophagy","volume":"16","author":"Edinger","year":"2004","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.biopha.2022.112694_bib44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nrmicro2929","article-title":"Cell death in parasitic protozoa: regulated or incidental?","volume":"11","author":"Proto","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.biopha.2022.112694_bib45","series-title":"Stud. Nat. Prod. Chem","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1572-5995(06)80030-X","article-title":"Structure-Activity Relationships of Sesquiterpene Lactones, in: B.T.-S. in N.P.C. Atta-ur-Rahman","author":"Schmidt","year":"2006"},{"key":"10.1016\/j.biopha.2022.112694_bib46","first-page":"4","article-title":"Toxic activities of sesquiterpene lactones: structural and biochemical aspects","volume":"3","author":"Schmidt","year":"1999","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.biopha.2022.112694_bib47","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0305-1978(86)90101-8","article-title":"Biological activities of sesquiterpene lactones","volume":"14","author":"Picman","year":"1986","journal-title":"Biochem. Syst. Ecol."},{"key":"10.1016\/j.biopha.2022.112694_bib48","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.drudis.2010.06.002","article-title":"What made sesquiterpene lactones reach cancer clinical trials?","volume":"15","author":"Ghantous","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2022.112694_bib49","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1126\/science.168.3929.376","article-title":"Reactions of alpha methylene lactone tumor inhibitors with model biological nucelophiles","volume":"168","author":"Kupchan","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.biopha.2022.112694_bib50","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1021\/jm00294a001","article-title":"Tumor inhibitors. 69. Structure-cytotoxicity relationships among the sesquiterpene lactones","volume":"14","author":"Kupchan","year":"1971","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112694_bib51","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.fitote.2011.05.010","article-title":"Antitrypanosomal sesquiterpene lactones from Saussurea costus","volume":"82","author":"Julianti","year":"2011","journal-title":"Fitoterapia"},{"key":"10.1016\/j.biopha.2022.112694_bib52","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.3390\/molecules14062062","article-title":"Quantitative structure--antiprotozoal activity relationships of sesquiterpene lactones","volume":"14","author":"Schmidt","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2022.112694_bib53","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1039\/C9NP00049F","article-title":"Advances in chemistry and bioactivity of parthenolide","volume":"37","author":"Freund","year":"2020","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.biopha.2022.112694_bib54","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.2174\/1381612825666191014171354","article-title":"Nanoparticle-mediated drug delivery: blood-brain barrier as the main obstacle to treating infectious diseases in CNS","volume":"25","author":"Gondim","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biopha.2022.112694_bib55","article-title":"Characteristics of compounds that cross the blood-brain barrier","volume":"Suppl 1","author":"Banks","year":"2009","journal-title":"BMC Neurol. 9"},{"key":"10.1016\/j.biopha.2022.112694_bib56","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13052-018-0563-0","article-title":"Possible strategies to cross the blood\u2013brain barrier","volume":"44","author":"Bellettato","year":"2018","journal-title":"Ital. J. Pedia"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222000828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222000828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:51:48Z","timestamp":1760100708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222000828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":56,"alternative-id":["S0753332222000828"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112694","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sesquiterpene lactones as potential therapeutic agents against Naegleria fowleri","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112694","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112694"}}